Neurodegenerative diseases, a group of clinical diseases including AD, Parkinson's disease, and others, are characterized by the accumulation of pathological proteins, such as Aβ, tau, and α-synuclein [2, 69]. This evidence concerns the gene MAPT and Alzheimer disease.